Chemical Reprogramming of Neuronal Cells via Small Molecule Composition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for reprogramming differentiated cells into neural stem cells are inefficient and require genetic engineering, which introduces mutations and involves heterogeneous populations, making it difficult to unambiguously define the origin of reprogrammed cells.
Innovation Solution
A composition comprising BMP type I receptor ALK2/3 inhibitors, TGF-beta inhibitors, WNT inhibitors, neuronal differentiation enhancers, SMO agonists, retinoic acid receptor γ agonists, DNA methyltransferase inhibitors, histone demethylase inhibitors, and autophagy regulators is used to chemically reprogram differentiated non-neuronal cells into neuronal progenitor and mature neuronal cells without genetic manipulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If genetic engineering methods are used to reprogram differentiated cells into neural stem cells, then reprogramming can be achieved, but genetic mutations are introduced and the process becomes complex
Solution Approach 1:
The patent replaces genetic engineering methods (mechanical/biological manipulation of DNA) with a chemical composition that uses small molecules to modulate signaling pathways. This substitution eliminates the need for viral transduction or transgenic manipulation, thereby avoiding insertional mutations while achieving the same reprogramming goal through chemical modulation of cellular processes
Solution Approach 2:
The patent changes the reprogramming approach from genetic parameter modification (introducing foreign genes) to chemical parameter modification (adjusting signaling pathway activity through small molecules). The composition targets multiple signaling pathways simultaneously, changing cellular behavior through parameter modulation rather than genetic alteration
2Reliability
If traditional reprogramming methods are used, then neural stem cells can be generated, but the process is time-consuming and labor-intensive
Solution Approach 1:
The patent merges multiple reprogramming functions into a single composition containing nine different small molecules. Each molecule targets a specific signaling pathway, and their combined action synergistically accelerates the reprogramming process. This consolidation of multiple functions into one treatment regimen reduces the number of separate steps and decreases overall processing time
Solution Approach 2:
The patent employs a composite chemical composition where nine different small molecules work together to achieve reprogramming. This composite approach allows simultaneous modulation of multiple cellular pathways, creating a coordinated effect that speeds up the reprogramming process compared to single-agent approaches
3Productivity
If MEFs are used as starting cells, then reprogramming can proceed, but the heterogeneous population makes it difficult to define cell origin
Solution Approach 1:
The patent applies lineage tracing technology to specifically mark and track the fibroblast population within the heterogeneous MEF culture. By using genetic markers that are locally applied to fibroblasts (such as Cre-lox systems or fluorescent protein tagging), the patent enables precise identification of fibroblast-derived cells among other cell types in the culture, thereby achieving accurate lineage tracing despite population heterogeneity
Data Source
AI summary
Compositions and methods are described herein for chemically inducing cells to change their differentiation state and become neuronal cells.